Mode
Text Size
Log in / Sign up

Narrative review suggests transcatheter PDA closure improves safety and reduces radiation compared to fluoroscopyA new way to close a heart hole uses less radiation and takes less time

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider transcatheter PDA closure for enhanced safety and reduced radiation versus fluoroscopy.

This narrative review examines the use of transcatheter closure for patent ductus arteriosus. The scope includes comparisons against the classical fluoroscopy approach regarding procedural safety, radiation exposure, procedure times, and eligibility criteria. The review does not report a specific sample size or follow-up duration. The authors synthesize qualitative conclusions rather than pooled effect sizes because the source is a narrative review. Specific numerical data, p-values, or confidence intervals are not reported in this source. The review does not detail adverse events or tolerability data. The authors acknowledge that specific effect sizes and absolute numbers were not reported for the outcomes analyzed. The review suggests that the intervention may offer benefits over the comparator but does not provide statistical certainty. The practice relevance is described as optimizing outcomes and guiding future practice in transcatheter PDA closure. Clinicians should interpret these findings within the context of a narrative review that lacks quantitative precision.

Many patients live with a patent ductus arteriosus, a small hole in the heart that should have closed after birth. Fixing this hole is important for their long-term health. Doctors often use a catheter to close it, but the process can involve radiation and take a while. A recent review looked at how a specific transcatheter closure method compares to the classical fluoroscopy approach.

This review found that the new method improves procedural safety. It also reduces the amount of radiation patients receive during the procedure. The time needed to complete the procedure is shortened as well. Additionally, more patients may now be eligible for this treatment.

The review did not report specific numbers for these improvements. It also did not report on adverse events or serious side effects. While the findings are promising, the evidence comes from a narrative review rather than a single large trial. This means the results are based on existing reports rather than new data from one specific group of patients.

These findings could help doctors optimize outcomes and guide future practice in transcatheter PDA closure. The goal is to make the procedure safer and more efficient for everyone who needs it.

What this means for you:
A new catheter method for closing a heart hole uses less radiation and takes less time.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Patent ductus arteriosus (PDA) is a common congenital cardiac defect traditionally managed by surgical and transcatheter closure under fluoroscopic guidance. Over recent years, significant advances in imaging modalities, device technology, and procedural planning have transformed the pathway for PDA closure, reducing reliance on classical fluoroscopy-based techniques. This review outlines the evolution of transcatheter PDA closure from conventional fluoroscopic approaches to contemporary strategies incorporating echocardiographic guidance, hybrid imaging, and radiation-sparing protocols. These changes have enhanced procedural safety, reduced radiation exposure to patients and operators, shortened procedure times, and expanded eligibility to younger and higher-risk populations. Understanding this evolving pathway is essential for optimizing outcomes and guiding future practice in transcatheter PDA closure.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.